These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 4064030

  • 1. Plasma carcinoembryonic antigen and tissue polypeptide antigen levels in lung cancer: correlation with cell types and stage.
    Salvati F, Antilli A, Cruciani AR, Pau F, Flore F, Munno R, De Angelis G, Cipri A, Pigorini F.
    Cancer Detect Prev; 1985; 8(1-2):111-4. PubMed ID: 4064030
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
    Pan QR, Zhang X, Xu ZF, Zheng S.
    Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
    [Abstract] [Full Text] [Related]

  • 5. Tissue polypeptide antigen and carcinoembryonic antigen in colon tumors: serum levels and immunohistochemical localization.
    Bombardieri E, Jotti GS, Cocciolo MG, Mori M, Rusconi A, Rusca M, Seregni E, Becchi G, Fontanesi M, Tardini A.
    Cancer Detect Prev; 1985 Feb; 8(1-2):219-26. PubMed ID: 4064041
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels.
    Slodkowska J, Szturmowicz M, Rudzinski P, Giedronowicz D, Sakowicz A, Androsiuk W, Zakrzewska-Rowinska E.
    Eur J Cancer Prev; 1998 Feb; 7(1):51-60. PubMed ID: 9511851
    [Abstract] [Full Text] [Related]

  • 9. [Tissue polypeptide antigen in serum and tissue in patients with lung cancer].
    Haga E.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Apr; 28(4):595-604. PubMed ID: 2170727
    [Abstract] [Full Text] [Related]

  • 10. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
    Picardo AL, Diez M, Torres A, Maestro M, Ortega D, Hernando F, Gómez A, Garcia-Asenjo J, Balibrea JL.
    Cancer; 1996 Mar 15; 77(6):1066-72. PubMed ID: 8635125
    [Abstract] [Full Text] [Related]

  • 11. [Tissue polypeptide and carcinoembryonic antigens in patients with breast cancer].
    Polevaia EB, Tkacheva GA, Ivanov VM, Koposova TL.
    Vopr Onkol; 1984 Mar 15; 30(3):9-13. PubMed ID: 6710954
    [Abstract] [Full Text] [Related]

  • 12. Biomarkers and IL-2R in lung cancer.
    Marino P, Preatoni A, Fonticoli L, Parodi M, Tarolo GL.
    Recenti Prog Med; 1990 Nov 15; 81(11):702-4. PubMed ID: 1962891
    [Abstract] [Full Text] [Related]

  • 13. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.
    Buccheri G, Ferrigno D.
    J Thorac Cardiovasc Surg; 2001 Nov 15; 122(5):891-9. PubMed ID: 11689793
    [Abstract] [Full Text] [Related]

  • 14. Comparison between tissue antigen analysis and plasma determinations for TPA and CEA in transitional cell carcinomas and in tumorfree urothelium of the urinary bladder.
    Vogel J, Oehr P, Maisey R, Adolphs HD.
    Cancer Detect Prev; 1988 Nov 15; 11(3-6):389-96. PubMed ID: 2455597
    [Abstract] [Full Text] [Related]

  • 15. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
    Björklund V, Björklund B.
    Cancer Detect Prev; 1983 Nov 15; 6(1-2):193-8. PubMed ID: 6883380
    [Abstract] [Full Text] [Related]

  • 16. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
    Foa P, Fornier M, Miceli R, Seregni E, Santambrogio L, Nosotti M, Cataldo I, Sala M, Caldiera S, Bombardieri E.
    Anticancer Res; 1999 Nov 15; 19(4C):3613-8. PubMed ID: 10629660
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K, Yonese Y, Nakagami Y, Minowa T, Hiraoka Y, Yamada N, Hikima N, Ishii Y, Tannowa K, Fujioka Y.
    Gan To Kagaku Ryoho; 1984 May 15; 11(5):1078-83. PubMed ID: 6721513
    [Abstract] [Full Text] [Related]

  • 18. Human tissue polypeptide antigen in breast cancer.
    Nemoto T, Constantine R, Chu TM.
    J Natl Cancer Inst; 1979 Dec 15; 63(6):1347-50. PubMed ID: 292806
    [Abstract] [Full Text] [Related]

  • 19. Tissue polypeptide antigen and carcinoembryonic antigen as tumor markers in lung cancer.
    Lee YC, Yang PC, Kuo SH, Luh KT.
    J Formos Med Assoc; 1991 Jul 15; 90(7):631-6. PubMed ID: 1681012
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
    Hotta K, Segawa Y, Takigawa N, Kishino D, Saeki H, Nakata M, Mandai K, Eguchi K.
    Anticancer Res; 2000 Jul 15; 20(3B):2177-80. PubMed ID: 10928173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.